+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Special Coagulation Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

  • PDF Icon

    Report

  • 46 Pages
  • June 2023
  • Region: Global
  • GlobalData
  • ID: 5640171
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Medical Devices sector report, “Special Coagulation Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Special Coagulation Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

These are reagents which are used to conduct special coagulation tests which provide quantitative determination of anticoagulant activities of heparin and thrombin formation.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Special Coagulation Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Special Coagulation Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Special Coagulation Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Special Coagulation Tests Overview
3 Products under Development
3.1 Special Coagulation Tests - Pipeline Products by Stage of Development
3.2 Special Coagulation Tests - Pipeline Products by Territory
3.3 Special Coagulation Tests - Pipeline Products by Regulatory Path
3.4 Special Coagulation Tests - Pipeline Products by Estimated Approval Date
4 Special Coagulation Tests - Pipeline Products under Development by Companies
4.1 Special Coagulation Tests Companies - Pipeline Products by Stage of Development
4.2 Special Coagulation Tests - Pipeline Products by Stage of Development
5 Special Coagulation Tests Companies and Product Overview
5.1 Diagnostica Stago Inc Company Overview
5.1.1 Diagnostica Stago Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Helena Laboratories Corp Company Overview
5.2.1 Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview
5.3 Instrumentation Laboratory Co Company Overview
5.3.1 Instrumentation Laboratory Co Pipeline Products & Ongoing Clinical Trials Overview
5.4 Massachusetts General Hospital Company Overview
5.4.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
5.5 Roche Diagnostics International Ltd Company Overview
5.5.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.6 Siemens Healthcare Diagnostics GmbH Company Overview
5.6.1 Siemens Healthcare Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.7 Siemens Healthcare Diagnostics Inc Company Overview
5.7.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 SQI Diagnostics Inc Company Overview
5.8.1 SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Special Coagulation Tests- Recent Developments
6.1 May 30, 2023: SQI Diagnostics reports second quarter 2023 results
6.2 Aug 29, 2022: SQI Diagnostics Reports Third Quarter 2022 Results
6.3 Jul 25, 2022: Beckman Coulter partners with Mass General and BARDA to identify severe pediatric infections in emergency departments
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer
List of Tables
  • Special Coagulation Tests - Pipeline Products by Stage of Development
  • Special Coagulation Tests - Pipeline Products by Territory
  • Special Coagulation Tests - Pipeline Products by Regulatory Path
  • Special Coagulation Tests - Pipeline Products by Estimated Approval Date
  • Special Coagulation Tests Companies - Pipeline Products by Stage of Development
  • Special Coagulation Tests - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Special Coagulation Tests - Pipeline Products by Stage of Development
  • Special Coagulation Tests - Pipeline Products by Territory
  • Special Coagulation Tests - Pipeline Products by Regulatory Path
  • Special Coagulation Tests - Pipeline Products by Estimated Approval Date

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Diagnostica Stago Inc
  • Helena Laboratories Corp
  • Instrumentation Laboratory Co
  • Massachusetts General Hospital
  • Roche Diagnostics International Ltd
  • Siemens Healthcare Diagnostics GmbH
  • Siemens Healthcare Diagnostics Inc
  • SQI Diagnostics Inc